WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹214 Cr | ₹320 Cr | ₹360 Cr | ₹355 Cr | ₹311 Cr |
What is the latest Total Current Liabilities ratio of WANBURY ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹214 Cr |
Mar2023 | ₹320 Cr |
Mar2022 | ₹360 Cr |
Mar2021 | ₹355 Cr |
Mar2020 | ₹311 Cr |
How is Total Current Liabilities of WANBURY Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹214 Cr | -33.10 | |
Mar2023 | ₹320 Cr | -11.05 | |
Mar2022 | ₹360 Cr | 1.24 | |
Mar2021 | ₹355 Cr | 14.25 | |
Mar2020 | ₹311 Cr | - |
Compare Total Current Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹842.9 Cr | -4.2% | 3.9% | 12.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,469.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,672.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹125,034.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,542.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,571.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -4.2% |
3.9% |
12.5% |
SENSEX | 1.2% |
1.9% |
-0.2% |
You may also like the below Video Courses